EXPLEOSOL.NS Stock Analysis
EX
Neutral
Based on Eyestock quantitative analysis, EXPLEOSOL.NS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Expleo Solutions Ltd. engages in the provision of software validation and verification services to the banking and financial services industry. The company is headquartered in Chennai, Tamil Nadu and currently employs 3,931 full-time employees. The company went IPO on 2009-10-26. The firm provides software services, which includes software validation and verification services, software development and engineering consultancy services related to aerospace, automotive, defense and rail industry, and banking, financial services and insurance (BFSI). The firm has capabilities in various fields, such as artificial intelligence (AI) engineering, digitalization, hyper-automation, cybersecurity and data science. The firm has invested in four wholly owned subsidiaries in Singapore, the Unites States of America, the United Kingdom and the United Arab Emirates for market development and service delivery in the respective regions. Its subsidiaries include Expleo Solutions Pte. Ltd., Expleo Solutions UK Ltd., Expleo Solutions Inc. and Expleo Solutions FZE.